Peptides mai zane & Haɗin Kan Al'ada: Channel zuwa Neuro Scaffolds

Peptides mai zane & Haɗin Kan Al'ada: Channel zuwa Neuro Scaffolds

Me yasa Scafold Shin Takaddama

“Peptide mai tsarawa” ba kasafai ba ne mai sauƙi mai layin layi. Azuzuwan aiki waɗanda ke mamaye tashar da wallafe-wallafen CNS suna buƙatar tsari bisa manufa.

Ion-tashar blockers da aka samu daga yanayi akai-akai guba mai wadatar disulfide. Scorpion α-KTx peptides, misali, riže m ninki tare da uku ko hudu disulfide bond, kuma wannan tsattsauran tsarin cysteine ​​shine abin da zai basu damar shiga cikin pore na tashar potassium tare da nuna wariya.. Maimaita wannan tsarin da synthetically, kuma kowane cysteine ​​ya zama matsalar regioselectivity: Sittin sittin na iya haɗawa da yawa zuwa isomers disulfide guda goma sha biyar, kuma tsari guda ɗaya ne kawai ke mayar da aiki mai ƙarfi.

Peptide Synthesis Peptides mai zane & Haɗin Kan Al'ada: Channel zuwa Neuro Scaffolds

'Yan takarar Neuroprotective suna zaune a ɗayan ƙarshen amma suna tayar da damuwa-hoton madubi. Matsalolin aiki galibi gajere ne kuma masu saurin kamuwa da cuta, don haka ƙungiyoyi sun isa ga ilimin kimiyyar kashin baya - cyclization da stapling su ne mafi inganci hanyoyin da za a kulle wani aiki conformation da kuma tsayayya da lalacewa, kamar yadda aiki akan nerinetide da CNS peptides masu alaƙa sun nuna. Kudin roba na gaske ne: macrocyclization ko madaidaicin hydrocarbon yana ƙara matakan amsawa, yana haifar da sabbin ƙazanta jama'a, kuma yana buƙatar tabbatar da rufaffiyar fom, ba kawai madaidaicin madaidaici ba.

Abin da wannan ke nufi don haɗawa ta al'ada ita ce madaidaiciya. Ba'a bayyana peptide ta farkon jerin sa kawai amma ta ninkinsa, da cysteine ​​topology, Peptides na roba wurin hawan kekensa, da tags ɗin da yake ɗauka. Kowannen waɗannan yanke shawara ne da yakamata ku sanya akan taƙaitaccen bayanin kafin hada guda ɗaya.

Peptides mai zane & Haɗin Kan Al'ada: Channel zuwa Neuro Scaffolds

Tari Shine Yanayin Kasawa Na Farko

Babu kayan peptide da ke karya ƙarin ayyuka a baya fiye da tarawa. Yayin taron Fmoc mai ƙarfi-lokaci, sarƙoƙi masu girma waɗanda ke da hydrophobic ko β-sheet-prone mai haɗin kai ta hanyar haɗin gwiwar hydrogen intermolecular kai tsaye akan guduro. Wannan rugujewar kan-ƙwanƙwasa yana toshe hanyar shigar amino acid da aka kunna, yana samar da mahaɗin da bai cika ba, kuma yana rubuta tsattsauran ra'ayi da gogewa a cikin jeri kafin a fara tsarkakewa.

Hanyar yanzu tana da siffa sosai. Aiki na baya-bayan nan a cikin Kimiyyar Halitta ya tabbatar da cewa abun da ke tattare da amino acid yana haifar da haɗuwa yayin haɗin peptide., yana nuna cewa jerin da kanta - ba kawai tsayinsa ba - yana sarrafa ko sarkar da aka karewa ta nannade cikin tsari na biyu mai hanawa akan tallafi.. Wannan ya yi daidai da dogon tarihin bincike a cikin abin da ake kira "jeri mai wuyar gaske,” wanda filin ya samo asali ne a kan-resin β-sheet wanda ke hana haɗin gwiwa da karewa.

Sigina masu amfani guda biyu suna hasashen matsala kafin jerin jiragen ruwa:

  • Gudun hydrophobic masu ci gaba mai arziki a Val, Tare da, Leu, da Phe. Waɗannan su ne tsoffin direbobin rushewar guduro.

  • Cajin gidan yanar gizo na kusa. Ba tare da ƙin Coulombic ba don riƙe sarƙoƙi a cikin bayani, Lambobin hydrophobic sun mamaye kuma peptide yana haɓakawa ko gels yayin tsagawa da kuma cikin buffer assay.

Saboda tashar-blocker da neuroprotective scaffolds durƙusad da hydrophobic kuma sau da yawa aiki kusa da isoelectric batu., Haɗarin haɗuwarsu na tsari ne, ba na kwatsam ba. Gudanar da shi - ta hanyar shigar pseudoproline, solubilizing tags, kariyar kashin baya, ƙananan guduro loading, ko haɗin gwiwar da aka taimaka ta microwave - wani ɓangare ne na ƙwarewar da aka saita wanda abokin haɗin gwiwa dole ne ya kawo, ba layin sabis na gama-gari ba. Abin nufi ga mai siye shi ne ya ba da alamar haɗari da wuri kuma a tilasta wa mai siyarwa ya faɗi yadda za a sarrafa shi.

Lakabi da Gyara: Kowane Tag Tsararren Tsare ne

Kusan duk wani binciken da aka shirya na peptide ya ƙare yana ɗaukar wani abu: hannun biotin don kamawa, fluorophore don hoto ko ɗaure, CPP don farawa, PEG ko lipid don kwanciyar hankali. Yawancin lokaci ana ɗaukar lakabin azaman tunani na baya. Ba - shi ne na biyu kwayoyin grafted uwa na farko.

Alamun suna canzawa a aunawa. A 2024 Binciken ya gano cewa alamar kyalli ya canza peptide-protein dissociation akai-akai ta kusan tsari na girma., tare da tasiri dangane da duka fluorophore da abokin tarayya. Hydrophobic da dyes da aka caje su ne mafi munin masu laifi saboda suna canza tari da tallan da ba na musamman ba.. Biotinylation ya fi karami amma har yanzu yana dagula kwayoyin halitta, haɓaka hydrophobicity da rage cajin ta hanyoyin da ke canza yadda peptide ke aiki akan ginshiƙi na LC-MS kuma a cikin binciken kamawa..

Dokokin da suka biyo baya ana iya canja su zuwa kowane ɓangarorin a cikin bakan tasha-zuwa-CNS:

  • Kiyaye pharmacophore mai tsabta. Sanya alamar a madaidaicin da aka fallasa mai ƙarfi ko a kan ragowar da aka sani ba zai taɓa abin da ake nufi ba.

  • Ware tambarin daga jigon bioactive tare da spacer kamar aminocaproic acid (Ahhh) ko gajeriyar hanyar haɗin PEG lokacin da sterics ke da mahimmanci.

  • Gwada fiye da ɗaya shafi Lokacin da epitope mai ɗaure ba shi da tabbas - peptide mai sassauƙa ko ɓangarori na iya jurewa rini a ɗayan ƙarshen kuma ba ɗayan ba..

  • Siffata ginin da aka yiwa lakabin a matsayin kwayoyin halittarsa, ba a matsayin wakili na shiru don peptide mara lakabi ba. Tabbatar da alaƙa da aiki don nau'ikan biyu.

Don arziƙin disulfide ko scaffolds masu keken keke akwai ƙarin ƙuntatawa: Dole ne sanya lakabin ya dagula ilimin nadawa ko hawan keke, don haka takamammen hannaye (misali lysine mai kariya ko cysteine) yawanci ana sanyawa akan guduro kafin kariya ta ƙarshe.

Tsarkake Hukuncin Aikace-aikace ne, Ba Lamba ba

Tsaftar da kuke nema ya kamata ta bi diddigin abin da a zahiri ke buƙata, kuma "high" ba ƙayyadaddun bayanai ba ne. Ƙofofin masu amfani suna da kyau a cikin masu samar da kayayyaki da wallafe-wallafen fasaha:

  • ≥95% HPLC tsarki yana goyan bayan mafi yawan in vitro bioassays, aikin antibody, da kuma karatun juzu'i.

  • ≥98% shine bene mai amfani don ƙididdigewa, tushen tantanin halitta, da gwaje-gwajen amsa kashi inda a 2% cakudewar ƙazanta na iya canza abin karantawa.

  • >98-99% an keɓe shi don aikin injiniyoyi masu mahimmanci kuma don nazarin da ke kan gaba ga da'awar tsarin ɗab'i.

Inda tashoshi da neuro scaffolds ke rikitarwa wannan abu ne mai sauƙi: peptide mai cyclized ko stapled wanda aka tsarkake zuwa 98% Tsaftar layi ba a ƙare ba idan wani juzu'i mai ma'ana bai taɓa rufewa cikin daidai sigar zagayowar ba. Takaddun tsafta mai dacewa dole ne ya haɗa da naɗewa daidai, daidai cycized nau'in, ba adadi mai yawa wanda ya dunƙule su tare. Abin da ya sa ƙwararrun masu siye ke tambayar masu samar da kayayyaki yadda aka ayyana tsafta bisa kowane bambance-bambancen kuma suka nace cewa Takaddar Bincike ta ba da rahoton tsarin da ake so..

Abubuwan da ake buƙata na ƙasa suna da mahimmanci daidai. Don ƙididdigar tushen tantanin halitta, tsarki kadai baya magance haihuwa ko Endotoxin load, wanda shine dalilin da ya sa tsarin inganci ya bambanta tsabtar chromatographic daga ƙananan ƙwayoyin cuta da abun ciki na pyrogen. Peptide zai iya zama 99% mai tsabta ta HPLC kuma har yanzu yana ɗauke da lipopolysaccharide wanda ke lalata bincike mai mahimmanci. Ƙayyade cikakken saitin ingantattun halayen da kuke buƙata, ba kawai kashi ɗaya ba.

Assay-Shirye Ma'anar Siffata, Ba Tsaftace Kawai ba

Kalmar “a shirye-shiryen tantancewa” ita ce inda mafi yawan alaƙar masu samarwa ko dai ta riƙe ko ta karye. Peptide yana shirye kawai don ingantaccen ilmin halitta idan ainihin sa, jeri, kuma an tabbatar da abun ciki, ba kawai idan babban kololuwar HPLC ɗinsa ya yi kyau ba.

Mafi ƙarancin fakitin ingantaccen aiki don amfanin aiki ya haɗa da RP-HPLC na nazari don tsaftar yanki mai kololuwa., Mass spectrometry don tabbatar da ingantaccen nauyin kwayoyin halitta, da - inda jerin aminci ko gyara dole ne a tabbatar - MS/MS peptide taswira. Don aikin ƙididdigewa, Ya kamata a yi amfani da nazarin amino acid don gyara ainihin abin da ke cikin peptide, saboda kashe danyen nauyi-a cikin taro maimakon ainihin abun ciki na peptide na gaskiya tushen kuskure ne mai shuru wanda ke yaduwa ta kowane taro na ƙasa.. Waɗannan su ne abubuwan Jagoran da ya dace da kima yana ba da shawarar haɗawa cikin Takaddun Takaddun Bincike.

Akwai rata mai kyau da aka rubuta filin yana jinkirin rufewa. A 2019 Bincike ya lura cewa peptides na roba na kusan saura 20-100 galibi ba a bayyana su ba a cikin nadawa da tsari mai girma uku., ko da a lokacin da aka ruwaito tsarki da jeri. Don mai hana tashar tashar disulfide mai wadatar ko ɗan takarar neuroprotective mai cyclized, Tabbatar da madaidaicin ninki da disulfide ko cyclization topology yana da mahimmanci da mahimmanci kamar tsabta - isomer mara kyau ko precursor wanda ba a rufe ba zai iya zama shiru ta ilimin halitta ko kuma yana aiki mai ruɗi.. Ƙayyade waɗannan sharuɗɗan karɓa a gaba, da tambayar wace hanya ce ta orthogonal (hadin kai, MS/MS taswira, CD, ko daidaitattun gwaje-gwaje) za a yi amfani da su don tabbatar da jihar da ake so, ita ce tambaya mafi girma guda ɗaya da mai siye zai iya yi.

Samar da Ƙwararren Peptide na Al'ada don Hard Scaffolds

Abin da ya haɗa duk wannan shine cewa iyawar peptide na al'ada ba game da tura wani tsari mai kyau ba ta hanyar layi na yau da kullum.. Yana da game da madaidaicin hanyar da za a zana - sarrafa tarawa akan jerin abubuwan hydrophobic masu wahala, shigar da takamaiman tambarin rukunin yanar gizo ba tare da keta tsarin disulfide ba, hawan keke da stapling ba tare da barin wani ɓangaren rufaffiyar samfuran ba, da goyan bayan kowane da'awar tare da kowane tsari na HPLC, taro, haihuwa, da bayanan abun ciki. Lokacin da waɗannan damar ke cikin wurin, canjin tashar-zuwa-neuroprotective ya zama matsalar sunadarai maimakon caca mai kaya. Samuwar Peptide

Ga ƙungiyoyin da ke gina waɗannan ɓangarorin da ake buƙata, MOL Canje-canje' dandamalin haɗin peptide na al'ada yana goyan bayan haɗakar dabarun irin waɗannan buƙatun bincike - m-lokaci, ruwa, da hanyoyin fermentation na ƙwayoyin cuta, a kan 300 gyare-gyaren sunadarai ciki har da cyclic, stapled, biotinylated, da kuma labeled peptides, tsarki har zuwa 99%, da Class 100 masana'anta bakararre tare da HPLC da takaddun ƙayyadaddun bayanai daga milligram zuwa sikelin kilogram. Tattaunawa jerinku, ninka niyya, kuma buƙatun sa na tantancewa a gaba shine hanya mafi sauri don juyar da peptide mai zane daga zane a cikin tsari wanda zaku iya amincewa da lab..

admin Avatar

Xiaoxia Chen

Sabon Drug R&D Masanin fasaha Ƙwararrun Ƙwararru: Gano manufa, alakar tsarin-aiki (SAR) bincike, peptide-magungunan magunguna (PDCs), da kuma ci gaban anti-tsufa da kuma na rayuwa peptides.

Bayanan martaba: Xiaoxia Chen ta jagoranci binciken farko da bincike na gaskiya don yawancin magunguna na peptide na rayuwa da ƙari.. Ba wai kawai ta ƙware a cikin babban aikin tantance ɗakunan karatu na peptide ba amma kuma ta kware wajen yin amfani da ilimin lissafi na taimakon AI don ƙirar jerin jerin peptide.. A halin yanzu, tana jagorantar ƙungiyar da aka sadaukar don bincike mai zurfi da haɓaka agonists masu yawa na gaba-gaba (kamar dual- ko peptides masu rage kitse masu niyya sau uku) da kuma sosai aiki nama-gyara peptides.

An Duba Gaskiyar & Jagoran Edita
Reviewed by: Kwararrun Maudu'i
Raba wannan labarin
Gida Bincika Whatsapp Ayyuka Samfura